Phenotype and Genotype of Pancreatic Cancer Cell Lines

By E. Deer, Jessica González-Hernández, J. Coursen, J. Shea, Josephat Ngatia, C. Scaife, M. Firpo, S. Mulvihill. Pancreas, 2010

862 citations recorded by the source corpus.

Abstract The dismal prognosis of pancreatic adenocarcinoma is due in part to a lack of molecular information regarding disease development. Established cell lines remain a useful tool for investigating these molecular events. Here we present a review of available information on commonly used pancreatic adenocarcinoma cell lines as a resource to help investigators select the cell lines most appropriate for their particular research needs. Information on clinical history; in vitro and in vivo growth characteristics; phenotypic characteristics, such as adhesion, invasion, migration, and tumorigenesis; and genotypic status of commonly altered genes (KRAS, p53, p16, and SMAD4) was evaluated. Identification of both consensus and discrepant information in the literature suggests careful evaluation before selection of cell lines and attention be given to cell line authentication.

Subfields: Biotechnology, Oncology

View Paper: https://www.semanticscholar.org/paper/53cfad1a1c0909149e7e34682e461a2a2bc864d2

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. A. Sher
2. Aldo Nascimento
3. F. Byrne
4. David F. Kashatus
5. Lindsey J. Myers
6. Jennifer A. Kashatus
7. Kyle L. Hoehn
8. C. Counter

Citations in the corpus

• Erk2 phosphorylation of Drp1 promotes mitochondrial fission and MAPK-driven tumor growth (2015, background): “6PL, MPanc96, and VMP 608t (Bruns et al., 1999; Deer et al., 2010; Moore et al., 2001; Stokes et al., 2011)—and one cell line with wild-type Ras—BxPC-3 (Diep et al.”